[Update on the risk of corticosterone therapy in combination with abiraterone acetate during the COVID-19 pandemic].

Rozet, F; Mongiat-Artus, P; Ploussard, G; Rouprêt, M; Cacoub, P; Fournier, G; Mathieu, R

[Update on the risk of corticosterone therapy in combination with abiraterone acetate during the COVID-19 pandemic]. / Actualisation du risque lié à la corticothérapie en association à l'acétate d'abiratérone en période de pandémie COVID-19.

Rozet, F; Mongiat-Artus, P; Ploussard, G; Rouprêt, M; Cacoub, P; Fournier, G; Mathieu, R.

Rozet F; Institut mutualiste Montsouris, université de Paris, 42, boulevard Jourdan, 75014 Paris, France. Electronic address: francois.rozet@imm.fr.
Mongiat-Artus P; Hôpital Saint-Louis, université de Paris, 1, avenue Claude-Vellefaux, 75010 Paris, France.
Ploussard G; Clinique La Croix du Sud, 52, chemin de Ribaute, 31130 Quint-Fonsegrives, France.
Rouprêt M; Hôpital Pitié-Salpêtrière, université Paris Sorbonne, 47-83, boulevard de l'Hôpital, 75013 Paris, France.
Cacoub P; Hôpital Pitié-Salpêtrière, université Paris Sorbonne, 47-83, boulevard de l'Hôpital, 75013 Paris, France.
Fournier G; Hôpital de La Cavale-Blanche, université de Bretagne occidentale, boulevard Tanguy-Prigent, 29200 Brest, France.
Mathieu R; Hôpital Pontchaillou, université Rennes 1, 2, rue Henri-le-Guilloux, 35000 Rennes, France.

Prog Urol ; 31(5): 243-244, 2021 04.

Article in French | MEDLINE | ID: covidwho-1038161

Subject(s)

Abiraterone Acetate/adverse effects; Adrenal Cortex Hormones/adverse effects; Androgen Antagonists/adverse effects; Antineoplastic Agents, Hormonal/adverse effects; Antineoplastic Combined Chemotherapy Protocols/adverse effects; COVID-19; Immunosuppressive Agents/adverse effects; Pandemics; SARS-CoV-2; Abiraterone Acetate/administration & dosage; Adenocarcinoma/drug therapy; Adenocarcinoma/secondary; Adrenal Cortex Hormones/administration & dosage; Androgen Antagonists/administration & dosage; Androgens; Antineoplastic Agents, Hormonal/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; COVID-19/therapy; Contraindications, Drug; Humans; Immunosuppressive Agents/administration & dosage; Male; Meta-Analysis as Topic; Neoplasms, Hormone-Dependent/drug therapy; Oxygen/therapeutic use; Practice Guidelines as Topic; Prospective Studies; Prostatic Neoplasms/drug therapy; Prostatic Neoplasms, Castration-Resistant/drug therapy; Randomized Controlled Trials as Topic; Respiration, Artificial; Risk

Keywords

Abiraterone acetate; Acétate d'abiratérone; COVID-19 pandemic; Corticotherapy; Corticothérapie; Pandémie COVID-19

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Adrenal Cortex Hormones / Antineoplastic Agents, Hormonal / Pandemics / Abiraterone Acetate / SARS-CoV-2 / COVID-19 / Immunosuppressive Agents / Androgen Antagonists Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials / Reviews Limits: Humans / Male Language: French Journal: Prog Urol Journal subject: Urology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google